Cargando…
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy
INTRODUCTION: Tau protein is a potential marker of neuronal damage. The aim of the study is to investigate its potential role as a marker of brain atrophy in multiple sclerosis (MS). MATERIALS AND METHODS: Cerebrospinal fluid (CSF) and blood samples were collected from 48 patients with multiple scle...
Autores principales: | Jaworski, Jacek, Psujek, Marek, Janczarek, Marzena, Szczerbo-Trojanowska, Małgorzata, Bartosik-Psujek, Halina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410288/ https://www.ncbi.nlm.nih.gov/pubmed/22554142 http://dx.doi.org/10.3109/03009734.2012.669423 |
Ejemplares similares
-
Risk Factors for Poor Adherence to Betaferon(®) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome
por: Jernas, Łukasz, et al.
Publicado: (2016) -
Worse Neurological State During Acute Ischemic Stroke is Associated with a Decrease in Serum Albumin Levels
por: Bielewicz, Joanna, et al.
Publicado: (2016) -
Primary diffuse meningeal melanomatosis – a rare form of meningeal melanoma: case report
por: Garbacz, Tomasz, et al.
Publicado: (2019) -
Selected factors determining the failure to undertake physical activity in patients with multiple sclerosis in Poland
por: Perenc, Lidia, et al.
Publicado: (2022) -
Silent Cerebral Infarcts Following Left-Sided Accessory Pathway Ablation in Wolff-Parkinson-White (WPW) Syndrome: A Preliminary Report
por: Głowniak, Andrzej, et al.
Publicado: (2019)